Loading clinical trials...
Loading clinical trials...
The ELG Analysis of Glucose a Correlational to Blood Glucose Assa
This study is an investigational study of the ELG medical device to monitor glucose blood level in diabetes mellitus Type 1 and 2 without blood samples in comparison to blood testing methods."Investigational" means the ELG medical device is subjected by the FDA (Food and Drug Administration) for premarket testing requirements. The purpose of this study is to collect data comparison values between ELG testing device to current blood testing methods.
Age
25 - 65 years
Sex
ALL
Healthy Volunteers
No
Rouse Family Medical Clinic
Springdale, Arkansas, United States
Start Date
August 11, 2021
Primary Completion Date
October 1, 2025
Completion Date
November 1, 2025
Last Updated
January 16, 2025
100
ESTIMATED participants
ELG
DEVICE
Lead Sponsor
XP Technology, LLC
NCT04786262
NCT06748963
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06959901